Modulation of excitatory neurotransmission by neuronal/glial signalling molecules: interplay between purinergic and glutamatergic systems

László Köles,Erzsébet Kató,Adrienn Hanuska,Zoltán S. Zádori,Mahmoud Al-Khrasani,Tibor Zelles,Patrizia Rubini,Peter Illes
DOI: https://doi.org/10.1007/s11302-015-9480-5
2015-11-06
Purinergic Signalling
Abstract:Glutamate is the main excitatory neurotransmitter of the central nervous system (CNS), released both from neurons and glial cells. Acting via ionotropic (NMDA, AMPA, kainate) and metabotropic glutamate receptors, it is critically involved in essential regulatory functions. Disturbances of glutamatergic neurotransmission can be detected in cognitive and neurodegenerative disorders. This paper summarizes the present knowledge on the modulation of glutamate-mediated responses in the CNS. Emphasis will be put on NMDA receptor channels, which are essential executive and integrative elements of the glutamatergic system. This receptor is crucial for proper functioning of neuronal circuits; its hypofunction or overactivation can result in neuronal disturbances and neurotoxicity. Somewhat surprisingly, NMDA receptors are not widely targeted by pharmacotherapy in clinics; their robust activation or inhibition seems to be desirable only in exceptional cases. However, their fine-tuning might provide a promising manipulation to optimize the activity of the glutamatergic system and to restore proper CNS function. This orchestration utilizes several neuromodulators. Besides the classical ones such as dopamine, novel candidates emerged in the last two decades. The purinergic system is a promising possibility to optimize the activity of the glutamatergic system. It exerts not only direct and indirect influences on NMDA receptors but, by modulating glutamatergic transmission, also plays an important role in glia-neuron communication. These purinergic functions will be illustrated mostly by depicting the modulatory role of the purinergic system on glutamatergic transmission in the prefrontal cortex, a CNS area important for attention, memory and learning.
neurosciences
What problem does this paper attempt to address?
The problems that this paper attempts to solve mainly focus on the following aspects: 1. **Regulation of Glutamatergic Neurotransmission**: The paper aims to summarize the current knowledge about the regulation of glutamatergic neurotransmission in the central nervous system (CNS), with particular emphasis on the role of NMDA receptor channels. Glutamate is the major excitatory neurotransmitter in the CNS and functions through ionotropic (NMDA, AMPA, kainic acid) and metabotropic glutamate receptors, participating in a variety of important regulatory functions. Disorders of glutamatergic neurotransmission are associated with cognitive impairment and neurodegenerative diseases. 2. **Function and Regulation of NMDA Receptors**: NMDA receptors are crucial for the normal function of neural circuits, and their hypofunction or over - activation may lead to neuronal dysfunction and neurotoxicity. The paper explores how NMDA receptors are finely regulated by multiple neuromodulatory molecules to optimize the activity of the glutamatergic system and restore the normal function of the CNS. 3. **Regulation of Glutamatergic Transmission by the Purinergic System**: In recent years, the purinergic system has attracted attention as a possible way to optimize the activity of the glutamatergic system. It not only directly and indirectly affects NMDA receptors but also plays an important role in the communication between glial cells and neurons by regulating glutamatergic transmission. The paper specifically discusses the regulatory role of purinergic in the prefrontal cortex, which is crucial for functions such as attention, memory, and learning. In summary, this paper mainly explores the regulatory mechanisms of glutamatergic neurotransmission, especially the key role of NMDA receptors in this process, and how the purinergic system affects glutamatergic transmission by regulating NMDA receptors, thus providing a new perspective for understanding neurophysiology and treating neurological diseases.